How did BPC 157 become the wellness industry's star peptide? FDA's Overreach on Compounded Peptides Are Peptides coming off of the FDA Category 2 list? A legal breakdown Holt Law In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University FDA Compliance for Peptide Therapy and BPC 157 Holt Law